Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Conditions
- Recurrent Fallopian Tube Carcinoma
- Recurrent Ovarian Carcinoma
- Recurrent Primary Peritoneal Carcinoma
Interventions
- BIOLOGICAL: Dalantercept
- OTHER: Laboratory Biomarker Analysis
Sponsor
Gynecologic Oncology Group
Collaborators